FDA approves Tosymra for acute treatment for headache attacks in migraine patients
-
Last Update: 2020-06-10
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
recently, DrReddy's(http://and its subsidiary Promius Pharma announced that the U.SFDA(http://approved the launch of Tosymra as an acute treatment for migraine attacks in migraine patientsto
Tosymra is a nasal spray that uses Aegis Therapeutics' Intravail technology to enhance the penetration ofdrug(http://The main ingredient of this therapy is sumatriptan (10 mg)Shumaqutam relieves pain by intercobing with serotonin receptors to inhibit the release of CGRPthis innovative formula allows Schumachertor to be quickly absorbed into the blood circulation, achieving pharmacokinetic characteristics similar to those of the subcutaneous injection of shumaqutamThis can take effect quickly to relieve pain symptomsstudies
107 migraine patients were treated with Tosymra or placebo in a multicenter, randomized double-blind, placebo-controlled clinicaltrial(http://test results showed that Tosymra significantly reduced the level of headache and associated symptoms during migraine attacksIn the Tosymra group, 43.8% of patients reached pain relief within 2 hours of treatment, compared with 22.5% (p 0.05) in the placebo groupCompared to placebo, Tosymra also significantly improved other symptoms that plagued patients most, including nausea and fear of light/sound (70.7% vs39.5%, p0.01)
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
